Exomind for OCD (Obsessive-Compulsive Disorder)
Exomind (rTMS) for OCD — an FDA-cleared adjunct treatment supported by clinical research, for patients whose OCD has not responded adequately to standard treatment.
rTMS received FDA clearance specifically for OCD in 2018, based on trials using a protocol targeting brain circuits associated with obsessive-compulsive symptoms, distinct from the standard depression protocol. This makes OCD one of the more clinically established, though still adjunctive, uses of rTMS beyond depression.
Dr. Muhammad Shoaib Zafar offers Exomind treatment for OCD as an adjunct for patients whose symptoms have not responded adequately to first-line Exposure and Response Prevention (ERP) therapy and medication.
Current Clinical Evidence
Clinical trials supporting FDA clearance for OCD demonstrated meaningful symptom reduction in patients using an OCD-specific rTMS protocol, targeting brain regions involved in the specific circuitry implicated in obsessive-compulsive symptoms, distinct from the DLPFC target used for depression.
Role as an Adjunct Treatment
rTMS for OCD is intended as an adjunct to, not a replacement for, first-line treatment with Exposure and Response Prevention (ERP) therapy and, where appropriate, medication such as SSRIs at OCD-specific doses, which remain the foundation of OCD treatment.
Investigational Aspects
While OCD-specific rTMS protocols have regulatory clearance, research continues into optimal protocols, patient selection, and long-term outcomes, and treatment decisions should be made individually in consultation with your psychiatrist.
Frequently Asked Questions
Frequently Asked Questions
Is rTMS a replacement for ERP therapy in OCD?
No, rTMS for OCD is intended as an adjunct alongside ERP therapy and appropriate medication, not a replacement for these established first-line treatments.
Is the OCD protocol the same as the depression protocol?
No, OCD-specific rTMS uses a different treatment protocol and brain target than the standard depression protocol, reflecting the distinct brain circuits involved.
Expert Care
Dr. Muhammad Shoaib Zafar offers Exomind as an evidence-based adjunct for OCD, always within a comprehensive treatment plan including ERP therapy.
This page is provided for general educational purposes and does not replace an individual psychiatric assessment.
Common signs & symptoms
- Recurrent, intrusive obsessive thoughts
- Compulsive behaviours performed to reduce anxiety
- Significant time spent on obsessions or compulsions
- OCD not responding adequately to ERP therapy or medication
Treatment approach
- → A structured course of rTMS targeting OCD-specific brain circuits
- → Used as an adjunct alongside ERP therapy and/or medication
- → Considered for OCD not responding adequately to standard treatment
Frequently asked questions
Is rTMS a replacement for ERP therapy in OCD?
No, rTMS for OCD is intended as an adjunct alongside ERP therapy and appropriate medication, not a replacement for these established first-line treatments.
Is the OCD protocol the same as the depression protocol?
No, OCD-specific rTMS uses a different treatment protocol and brain target than the standard depression protocol, reflecting the distinct brain circuits involved.